Full name
NEXTPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.10.Z - Manufacture of basic pharmaceutical products
10.8 - Production of other food products
11.07.Z - Production of non-alcoholic beverages and bottled water
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
47 - Retail trade
49 - Land transport and transport via pipelines
52 - Warehousing, storage, and support activities for transport
58 - Publishing activities
62 - Activities related to programming, IT consulting, and related activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 1,1 | -14,9 | -5,8 | 61,2 |
Gross profit (loss) | -4,5 | -33,7 | -8 | 76,4 |
EBITDA | 1,1 | -26,7 | -5,8 | 78,4 |
Short time liabilities | 267,2 | 19 | 29,5 | 55,3 |
Other operating costs | 0 | 11,9 | 0 | -100 |
Equity capital | 131 | 97,2 | 89,2 | -8,2 |
Operating profit (EBIT) | 1,1 | -26,7 | -5,8 | 78,4 |
Assets | 424,6 | 116,2 | 118,7 | 2,2 |
Net profit (loss) | -4,5 | -33,7 | -8 | 76,4 |
Cash | 12 | 0,1 | 1,4 | 2297,3 |
Net income from sale | 3,2 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 293,6 | 19 | 29,5 | 55,3 |
Working assets | 23 | 10,4 | 12,9 | 24,5 |
Other income costs | 0 | 0 | 0 | -100 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -3,4 | -34,7 | -8,9 | 25,8 |
Equity capital to total assets | 30,8 | 83,7 | 75,2 | -8,5 |
Gross profit margin | -141,2 | 1006,5 | ||
EBITDA Margin | 33,9 | 1128,4 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 30 475 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.08602876961231232 | 0.5460605025291443 | 0.4375371038913727 | -0,1 |
Net dept to EBITDA | 234.8187713623047 | -0.7084029912948608 | -4.714105606079102 | -4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane